FIELD: biotechnology.
SUBSTANCE: hybrid polypeptides are produced, that are capable of inducing an immune response against X1 in an animal other than a human, according to formula I and II NH2-S2-X1-COOH (formula I) NH2-S4-X2-S3-S2-X1-S1-S0-COOH (formula II), where X1 contains an amino acid sequence that is a target antigen or an immunogenic sequence and optionally includes a linker or adapter sequence, denotes a peptide bond, S1 and S2 are a pair of sequences of SEQ ID NO: 3 and 2, respectively.
EFFECT: invention allows to effectively achieve an immune response to the target antigen and to obtain antibodies to the target antigen.
14 cl, 40 dwg, 2 tbl, 17 ex
Title | Year | Author | Number |
---|---|---|---|
BISPECIFIC ANTIBODIES | 2011 |
|
RU2573588C2 |
OspA CHIMERIC GENES, PROTEINS, AND METHODS FOR THEIR USE | 2011 |
|
RU2636455C2 |
HUMANISED HUMAN CD19 ANTIBODIES AND METHODS FOR USE THEREOF | 2016 |
|
RU2731156C1 |
METHOD FOR SELECTION AND OBTAINING OF HIGHLY SELECTIVE AND MULTISPECIFIC TARGETING GROUPS WITH SPECIFIED PROPERTIES, INCLUDING AT LEAST TWO DIFFERENT BINDING GROUPS, AND THEIR APPLICATIONS | 2013 |
|
RU2639287C2 |
ANTIBODIES AGAINST A2 TENASTIN-C AND METHODS FOR USE THEREOF | 2011 |
|
RU2584597C2 |
METHOD FOR SELECTION AND PRODUCTION OF SELECTIVE AND MULTISPECIFIC THERAPEUTIC MOLECULES WITH SPECIFIED PROPERTIES, INCLUDING, AT LEAST TWO, DIFFERENT TARGET GROUPS, AND THEIR APPLICATIONS | 2013 |
|
RU2644263C2 |
CHIMERIC ANTIGENIC RECEPTORS AIMED AT ANTIGEN OF AGING OF B-CELLS | 2016 |
|
RU2706582C2 |
BINDING POLYPEPTIDES AND USE THEREOF | 2006 |
|
RU2470941C2 |
BISPECIFIC ANTIBODIES TO HUMAN CD20/HUMAN TRANSFERRIN RECEPTOR AND METHODS FOR THEIR USE | 2016 |
|
RU2753390C1 |
OSPA CHIMERIC GENES, PROTEINS AND METHODS FOR USE THEREOF | 2011 |
|
RU2583289C2 |
Authors
Dates
2017-09-11—Published
2012-05-04—Filed